Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
1. Doximity acquires Pathway Medical for $63 million, enhancing AI capabilities. 2. Pathway offers a robust clinical tool sourced from medical literature. 3. Doximity's stock has increased 8% this year and 90% in 2024. 4. Integration with Pathway is in progress, involving thousands of doctors. 5. Quarterly investor call scheduled for Thursday will discuss first-quarter results.